Abstract:Ethnopharmacological relevance Chang-Kang-Fang (CKF) is a traditional Chinese herbal formula used for treatment of irritable bowel syndrome (IBS) in China Decoction is the administration form of CKF in clinical practice. Previously, CKF has been confirmed with activities of releasing pain and reversing disorders of intestinal propulsion. And alkaloids, monoglycosides, chromones were found as the main bioactive components potentially contributing to the efficacy of CKF. Polysaccharide was also a major constituent in CKF. But if and how polysaccharides influence the systemic exposure of bioactive components in CKF is unknown. Aim of the study In this study, we aimed to demonstrate the contribution of the co-existed polysaccharides on the systemic exposure of the major bioactive components from CKF in normal and IBS model rats. Materials and methods An UPLC-TQ-MS with multiple reaction monitoring (MRM) scan method was developed and validated for quantifying six major small molecular bioactive ingredients of CKF in the plasma samples, including magnoflorine (MAG), berberine (BBR), albiflorin (ALB), paeoniflorin (PAE), 5- O -methylvisamminol (5-OM) and prim - O -glucosylcimifugin (POG). The rats received CKF decoction (CKF) and CKF small molecule portion (knockout of polysaccharides, CKFSM), respectively. IBS model rats were induced by daily bondage and gavage of Sennae Folium decoction (derived from the leaf of Cassia angustifolia Vahl). The effects of the co-existing polysaccharides on the pharmacokinetic parameters of six small molecular bioactive components in normal and IBS model rats were systematically evaluated. The potential gut microbiota involved mechanisms of the effects was validated by broad-spectrum antibiotic (ABX) treatment. Results The selectivity, precision, accuracy, recovery and matrix effect of the established quantification method were all within acceptable limits of biological sample. In normal rats, the co-existing polysaccharides significantly reduced the AUC (0-t) of MAG and PAE compared with CKFSM group. The C max and AUC (0-t) of other four compound were not influenced by co-existing polysaccharides. However, in IBS model rats, compared with CKFSM group, the C max and AUC (0-t) of the six ingredients significantly increased in CKF group. For CKF + ABX group, the C max of six ingredients decreased significantly when compared with CKF group, and the AUC (0-t) of MAG, BBR, ALB, PAE also reduced with significant differences. Conclusions A reliable and sensitive UPLC-TQ-MS method was successfully developed and validated for evaluating influence of co-existing polysaccharides on pharmacokinetic behavior of six major small molecules components in CKF. The co-existing polysaccharides enhanced the systemic exposure of six bioactive small molecules in CKF under IBS pathological state potentially via gut microbiota involvement.

Progress on pharmacology and clinical research of calcium polycarbophil

Efficacy and Safety of Calcium Polycarbophil in the Treatment of Constipation-Predominant Irritable Bowel Syndrome

Treatment of Functional Constipation with Compound Sodium Bicarbonate Suppository: A Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Study

Co-existing polysaccharides affect the systemic exposure of major bioactive ingredients in Chang-Kang-Fang, a multi-herb prescription for treatment of irritable bowel syndrome

Effect of inulin in the treatment of irritable bowel syndrome with constipation (Review)

Preclinical pharmacokinetics-related pharmacological effects of orally administered polysaccharides from traditional Chinese medicines: A review

Protein-polysaccharide-based delivery systems for enhancing the bioavailability of curcumin: A review

Effect and mechanism of Lycium barbarum polysaccharide on gastrointestinal motility in slow transit constipation

Efficacy and Safety of Traditional Chinese Herbal Medicine for Antipsychotic-Related Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

In Vitro Gastrointestinal Digestion of Polyonatum cyrtonema Polysaccharides and Impact on Intestinal Flora

THE CLINICAL STUDY OF THE EFFECTS OF PROBIOTICS IN PATIENTS WITH CONSTIPATION AND DIARRHEA

Progress of Clinical Research in Treatment of Chronic Constipation

Chinese patent medicine for treatment of chronic constipation in the elderly

Calcium polystyrene sulfonate in treating hyperkalemia patients with chronic kidney disease: a multi-center clinical study

Calcium polystyrene sulfonate-induced colitis: advanced characterization of crystal nature with infrared spectroscopy

Network pharmacology based research into the effect and potential mechanism of Portulaca oleracea L . polysaccharide against ulcerative colitis

Use of calcium carbonate as an excipient for release of poorly water soluble drugs: The case of carbamazepine

Efficacy of High Specific Volume Polysaccharide - A New Type of Dietary Fiber - On Molecular Mechanism of Intestinal Water Metabolism in Rats With Constipation

Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents

In vivo absorption, in vitro simulated digestion, and fecal fermentation properties of Imperata cylindrica polysaccharides and their effects on gut microbiota

Clinical effects of chemical drugs, fecal microbiota transplantation, probiotics, dietary fiber, and acupuncture in the treatment of chronic functional constipation: a systematic review and network meta-analysis